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Synthetic biology holds great promise to deliver transformative technologies to the world
in the coming years. However, several challenges still remain to be addressed before
it can deliver on its promises. One of the most important issues to address is the lack
of reproducibility within research of the life sciences. This problem is beginning to be
recognised by the community and solutions are being developed to tackle the problem.
The recent emergence of automated facilities that are open for use by researchers (such
as biofoundries and cloud labs) may be one of the ways that synthetic biologists can
improve the quality and reproducibility of their work. In this perspective article, we outline
these and some of the other technologies that are currently being developed which we
believe may help to transform how synthetic biologists approach their research activities.
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INTRODUCTION
Science is reliant on the development of reproducible data. Despite the great importance
of reproducibility, there have so far been few studies into the reproducibility of life science
publications. One exception is within cancer biology, where it was reported that only 11% of
landmark cancer studies could be reproduced (Begley and Ellis, 2012). In a survey of research
scientists, 77% of biologists stated that they had tried and failed to reproduce someone else’s result
in the lab (Baker, 2016). And when asked “what percentage of published results in your field are
reproducible?”, biologists estimated that only 59% of results are reproducible.
Different measures have been taken to maintain high levels of rigor within the sciences. The
process of peer-review is one of these measures and has so far served as a successful strategy.
However, with the increasing volume, complexity, and detail of data that is being published,
peer-review is arguably unable to ensure that published research is reproducible and othermeasures
are needed prior to this step.
Synthetic biology aims to introduce engineering principles into the life sciences in the hope
that it can greatly improve the reliability of the “Design-Build-Test-Learn cycle” (Figure 1). Any
engineering discipline must be predictable and reproducible. In this perspective article, we discuss
some of the ways the synthetic biology community is working towards achieving these goals.
IMPROVEMENT OF EXISTING LABORATORY PRACTICES
One way to increase reproducibility is to increase the quality of protocol reporting. Experimental
protocols are often specific to a laboratory or even to a single researcher, and are frequently taught to
new lab members through a combination of practical guidance and a written protocol. This form of
knowledge transfer is valuable in passing on tacit information (knowledge that is difficult to pass on
in written form), but can lead to variation in the way experiments are performed. The passing on of
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written protocols without practical guidance can lead to even
more problems, as written protocols are open to interpretation as
they often contain ambiguities or rely on tacit knowledge (Miles
and Lee, 2018). Online protocol editors, such as protocols.io, aim
to improve the quality of protocols by creating a platform for
scientists to easily share and edit protocol documents (Teytelman
et al., 2016). Researchers are encouraged to upload detailed step-
by-step instructions that can be followed, verified, and improved
upon by researchers from other labs. In addition, videos can also
be uploaded to capture some of the tacit information inherent in
performing experiments. These protocols can then be linked to
the methods sections of papers, and perhaps can help to improve
the standardisation of common techniques and thereby improve
experimental reproducibility.
Protocol editors combined with protocol management
systems can provide a framework for labs to organise their
research activities. The Aquarium software developed at the
Klavins Lab is an example of such a system1. In this system a
“designer” can accurately specify a protocol, which is then sent
to the lab as a “job” to be performed by students, technicians,
or robots. The system can be integrated with a laboratory
information management system (LIMS) such as Benchling,
enabling the use of materials to be tracked and giving trace-back
of the items used for each experiment.
AUTOMATION
For many years, laboratory automation has promised to
revolutionise biology. However, the incorporation of traditional
lab automation technologies (such as liquid handling robots) by
academic labs has been slight. However, many of the techniques
used within synthetic biology are performed on a routine basis,
and as such may be desirable targets for automation. The
successful implementation of automation technology can help to
improve both the throughput and reproducibility of experiments,
although the high cost and lack of flexibility of traditional
lab automation has so far hindered their wide-spread adoption
in academia. Recently though, there have been advances in
automation technology that, when combined with new protocol
sharing methods and protocol management systems, may allow
for researchers to gain the benefits of automation.
The pharmaceutical industry has found particular favour with
automation, as assay protocols are relatively simple to automate
(Bogue, 2012). The high cash flow within large companies gives
them the ability to invest in high quality and highly specialized
equipment. This approach is unlikely to function well in an
academic environment as the high costs and low flexibility of
these operations are often prohibitive. Flexible and low cost
solutions have generally not been offered by established vendors
of liquid handling robots. Liquid handlers from vendors such
as Tecan and Hamilton are state of the art, but expensive,
large, and technically complex. In addition, operation of these
machines usually requires skilled technicians, and can still take
several months before they are operational. Interestingly, a recent
Kickstarter campaign from Opentrons has aimed to address both
1https://www.aquarium.bio
the demand for a low cost and flexible liquid handler. The
resulting OT-One robot has proved popular in both academia
and industry, enabling Opentrons to establish itself in the field
of lab automation. The more recent and advanced OT-2 liquid
handler can be purchased from 4,000 USD, making it affordable
to a wide range of academic labs. They have addressed the issue
of flexibility through the adoption of open-source hardware and
software. The relative ease of set-up and use of the Opentrons
robots (programmable through a Python API, or soon through a
graphical user interface) enables it to be used in a flexible manner
by non-specialized workers. This means that many labs now have
the opportunity to automate parts of their workflows and share
their efforts throughout the community. The simple sharing of
protocols will hopefully mean that other labs can easily test and
verify the work of others.
Another issue that has been a problem for increased
implementation of automation systems until recently, is that it
has been difficult to link up devices from different manufacturers.
Synthace is a start-up that aims to eliminate this issue by
developing software that can control multiple robots from
different vendors. An entire lab may be able to be controlled
through a unified piece of software that allows for much simpler
coordinated control of complex automation equipment.
Contrary to liquid handling robots, microfluidic technologies
allow for the control of liquids on a microscopic scale and
can also be used to automate and scale down many common
laboratory procedures. Commercial microfluidic devices are
becoming increasingly commonplace in the lab, with devices
popular in the handling of DNA and RNA, such as fragment
analysers used in next-generation sequencing workflows. The
field of microfluidics is large and well-established, with over
3,000 articles published in 2017 alone (PubMed search for
keyword: “microfluidic”). Microfluidics may provide a cheap
and powerful alternative to traditional laboratory automation.
Devices have been built that are capable of performing strain
transformation and culturing, while other developments in the
field have focused on DNA assembly (Ben Yehezkel et al., 2016;
Gach et al., 2016; Linshiz et al., 2016). Even though microfluidic
devices have been shown capable of automating protocols within
synthetic biology, their adoption has been slow, and traditional
liquid handlers remain the dominant method of automation,
as the majority of laboratory automation has been designed
to handle the array formats (such as 96 well plates) that are
standard in the lab. Marrying microfluidic technologies to array-
based laboratory automation can prove difficult, and is perhaps
one reason for the limited integration of microfluidics into
automated workflows.
Tedious and repetitive tasks are highly error-prone for
humans to conduct, and automation may be seen as a way
to reduce such error (Yeow et al., 2014). However, careful
consideration for the requirements of any automation system
must be carried out before the purchase of equipment.
Counterintuitively, robots may be slower and less accurate than
humans under certain conditions. Zielinski et al. (2014) reported
that their newly developed pipetting protocol had up to a 3x
larger coefficient of variation and took twice as long to perform
when carried out by a robotic liquid handler rather than by
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FIGURE 1 | Moving towards automation in the Design-Test-Build-Learn cycle for enhancing the throughput and reliability of biological experimentation.
a human. Traditional liquid handlers are also limited in ways
such as requiring “dead volumes” of reagents inside wells, which
can increase the cost of experiments. To maintain high levels
of accuracy, all automation equipment must undergo strict
and frequent quality assessments (Chai et al., 2013). There is
an additional investment of time required for the set-up and
optimisation of new protocols, which when combined with
the aforementioned issues can dissuade academic labs from
purchasing such systems. However, as we discuss below, there
have recently been developments that aim to give researchers
easier access to automation.
BIOFOUNDRIES
The issues mentioned in the previous section can prevent
academic labs from investing in extensive automation. However,
in the past few years there has been a movement to create fully
or semi-automated labs termed “biofoundries.” Biofoundries
typically consist of a core laboratory that has been extensively
automated to carry out a range of functions. These integrated
systems are unique in their flexibility compared to standard
automated pipelines. A user can submit a job (e.g., create
a combinatorial library) to the biofoundry, where it will be
scheduled before being carried out by the automated lab. Once
a job has been successfully run, the user is sent (if applicable) the
biological output of their job along with any experimental or log
data that the user requires.
Much of the work conducted within synthetic biology revolves
around DNA manipulation, and as such so does the work
of many of the biofoundries. One example is the Edinburgh
Genome Foundry; whose focus is on manufacturing long lengths
of genetic material via several DNA assembly methods. Their
approach differs from that of a standard laboratory by only
requiring a minimum of human intervention. A range of
standard equipment, such as thermocyclers and incubators, are
linked together by a network of robotic arms that can carry plates
and samples between instruments. They are able to construct
and transform complex sections of DNA into host organisms
and then conduct a range of experiments on the engineered
strains. The minimisation of human intervention, and shared use
of reagent resources helps to bring down costs, hopefully to a
point where it becomes economically viable for many researchers
to outsource parts of their construction workflows to facilities
like this.
The UK and US are currently leaders in the development
of biofoundries, with several found throughout both countries
(Chao et al., 2017). Many of these are open to accepting jobs
from outside their host university institutes with the goal to
serve the wider scientific community (Table 1). A widespread
use of these facilities for design construction within synthetic
biology may help improve standardisation within the field, if the
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TABLE 1 | Overview of Biofoundries based at public institutions around the world.
Name of biofoundry Host organisation Focus Website
Agile BioFoundry US Department of Energy,
University of California, USA
Full integration of the Design-Build-Test-Learn cycle,
with advanced scale-up capabilities
https://agilebiofoundry.org
BIOFAB University of Washington, USA Use of the Aquarium software to control the
functioning of a traditional lab. Services focus on




Concordia University, Canada Cloning and NGS sample preparation https://www.concordia.ca/research/casb/
genome-foundry.html
DAMP lab Boston University, USA DNA construction, NGS preparations, protein
expression and purification
https://www.damplab.org





Edinburgh University, UK Assembly of large DNA fragments (>5,000 nt) https://www.genomefoundry.org/home
GeneMill University of Liverpool, UK DNA construction, screening, and metabolomics
workflows
https://genemill.liv.ac.uk
iBioFAB University of Illinois, USA Full automation of the Design-Build-Test-Learn cycle https://www.igb.illinois.edu/research-areas/
biosystems-design/research
London DNA Foundry Imperial College, UK Design and construction of complex DNA assemblies http://www.londondnafoundry.co.uk
NUS Synthetic Biology
Foundry
National University of Singapore,
Singapore
DNA assembly, and analytical capabilities for
downstream performance measurements
http://syncti.org/synthetic-biology-foundry/
SYNBIOCHEM University of Manchester, UK Automating the Design-Build-Test-Learn cycle for
production of fine chemicals
http://synbiochem.co.uk/synbiochem-pipeline/
This is not a comprehensive list, but contains those centres and facilities that have accessible webpages.
community of biofoundries agree upon the design and adoption
of operational standards.
CLOUD LABORATORIES
A similar concept to biofoundries is the “cloud laboratory.”
Like a biofoundry, a cloud lab is usually comprised of a central
facility that is heavily automated. However, the cloud lab gives
a higher level of freedom to the customer by offering a real
lab and its capabilities to biologists sat behind a computer
in a remote location (Check Hayden, 2014). Two Californian
companies have spearheaded this movement; Transcriptic, and
the Emerald Cloud Lab. Both companies offer their extensive
lab automation as a service, although each in a different
way. Transcriptic has constructed a series of sterile work-cells.
Within each work-cell is a set of basic lab equipment such as
liquid handlers, thermocyclers, fridges, incubator, and a plate
reader as well as a robotic arm to move materials between
machines. Customers can control the actions within a work-
cell via an application programming interface (API). A user can
create an experimental protocol through the high-level Python
API, which then converts the user’s protocol into the JSON-
formatted Autoprotocol language developed by Transcriptic to
control their automation equipment (Miles and Lee, 2018). Users
receive detailed results and diagnostics on their experiments,
with troubleshooting on failed experiments made easier by the
available metrics for all instruments on the executed run. The
Emerald Cloud Lab has taken a different approach, where they
have not broken down operations into discrete and identical
work-cells, but have instead focused on offering a wider and
more flexible range of services to the customer. The Emerald
Cloud Lab has a stronger focus on the analytical side of biology
through access to high-pressure liquid chromatography andmass
spectrometry, among others. Cloud labs offer the chance for
experimentalists to keep full control over their process, while also
providing detailed and reproducible protocols. The hope is that
academics will include these protocols within their publications,
and share them online where others can use or modify them.
Cloud labs may also enable early-stage biotech start-ups to test
their early ideas and designs without the need for investing in
setting up their own laboratory beforehand or entering into an
incubator too early. However, there are still limitations with
these technologies. Perhaps the most important is that it may be
impossible to have any one facility that can cater to the needs of
all biological researchers, since scientists make use of a wide array
of instrumentation in their routine experiments. A recent review
into cloud labs found that within biomedical research, 89% of
published papers were found to contain one or more methods
that could be carried out at a cloud lab (Groth and Cox, 2017).
However, only 3% of papers had all of their methods supported
by a cloud lab, suggesting that most complete workflows are as
yet unable to be ported to a cloud lab. While it may not be
necessary for a lab to implement complete workflows at a cloud
lab, it may also prove disadvantageous to only perform a small
part of their protocols (for example if it requires the frequent
shipping of materials). There is therefore an inevitable judgement
call that must be made to determine when it becomes beneficial
to outsource a protocol.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 4 February 2019 | Volume 7 | Article 18
Jessop-Fabre and Sonnenschein Improving Reproducibility in Synthetic Biology
THE ROBOT SCIENTIST
The robust development of lab automation, whether in-
house or through a biofoundry or cloud lab, may lead to
biologists automating parts of their hypothesis generation and
experimental design cycle too. While both biofoundries and
cloud labs implement instructions from a human operator, the
robot scientist aims to go one step further by removing the
scientist from the hypothesis generation and experimental design
steps. An early pioneering effort in this field was the creation
of a “Robot Scientist” named Adam (King et al., 2004, 2009).
The physical design of Adam resembles that of a biofoundry,
with several instruments handling the execution of a set of
experimental techniques. Materials are moved between these
instruments by three robotic arms, and the entire set-up is
enclosed in a sterile plastic enclosure. The main difference to
a biofoundry is that Adam has generated its own scientific
hypotheses, which it then tests experimentally, resulting in the
generation of new scientific knowledge in yeast genetics. Adam is
not alone. Themore recent Eve Robot Scientist has also generated
novel scientific insights, this time revealing new drug candidates
for the treatment of Plasmodium vivax (Williams et al., 2015).
Thismarriage of automation and basic hypothesis generation and
testing may prove to be valuable within synthetic biology, as a
researcher can be left to generate higher level hypotheses, which
are then interpreted and executed by an automated facility.
STANDARDISATION
One of the key enablers of engineering disciplines is the adoption
of a comprehensive set of standards (O’Connell, 1993). Such
levels of standardisation are much more difficult to achieve in
biological rather than electrical systems as there is a higher
degree of uncertainty in the systems being engineered (Endy,
2005; Arkin, 2008; Canton et al., 2008). As an example, if one
takes a regulatory element from one organism and places it in
another organism then it is likely that the functionality of that
element will differ. Even between different strains of the same
species there is a large variation in how genetic elements are
influenced by the host (Balagaddé et al., 2005; Cardinale et al.,
2013). Synthetic biology requires standards that can cope with the
issue of context dependency. Attempts to introduce standards,
such as the biobrick standard, have been so far unable to fully
deal with this issue (Decoene et al., 2018). However, promising
work is being done to improve the orthogonality of biological
parts (Stanton et al., 2013; Qian et al., 2017). Advances are also
being made in to how biological parts are characterised and
how orthogonality can be measured (Lucks et al., 2008; Mutalik
et al., 2013; Ceroni et al., 2015). The creation of such standards
may then help biofoundries and cloud labs to run standard
building and characterisation protocols, that when combined
with a developed set of operational standards can help to further
increase the reliability and reproducibility of synthetic biology
workflows. The standardisation of data practices is also just as
vital, as the greatest of experimental results are worthless without
the ability to learn from them, but such a discussion is out
of the scope of this article [for a deeper discussion on data
standardisation we refer the reader to Decoene et al. (2018)].
CONCLUSIONS
One important question to address in synthetic biology is,
how do we increase the predictability of our designed circuits
and strains? Answering this question will have wide-reaching
consequences for the field, but will require a shift in how synthetic
biology is carried out in academia. Although synthetic biology
has already broken the mould in many respects for how science
is conducted at universities, deeper changes are needed in the
funding and publishing infrastructures to guide the development
of standardised practices.
In the meantime, recent developments in laboratory
automation may help to improve the quality of experimental
protocols, as machines must be programmed with precise
and unambiguous instructions and protocols can be widely
distributed and validated between labs around the world. The
use of third-party facilities such as cloud labs or biofoundries can
reduce some of the experimental variation between researchers
while also reducing some of the burden. As we now order
primers (and genes) instead of making them ourselves, perhaps
we will soon too routinely order engineered strains. Robust
lab automation holds the potential to bring computer-aided
manufacturing (CAM) to synthetic biology by coupling
computer-aided design (CAD) software for biological systems
to the construction of cell factories, biological computers, and
novel enzymes (Raman et al., 2009; Vasilev et al., 2011; Nielsen
et al., 2016; Roehner et al., 2016; Cardoso et al., 2018).
There is an ever-growing demand for (high quality)
data for machine learning applications, which requires
a systematic approach to data generation, management,
and sharing. Automation is capable of providing this
approach as it can provide detailed logs of experimental
runs and of the data acquisition from instruments. The data
produced by academic labs needs to be made available to
the greater scientific community in standardised formats,
so that the greater community can learn from each other.
Data collection and management is an area that requires
a lot of attention. Although we have not had the space
to offer a detailed discussion here, the synthetic biology
community would greatly benefit from more focus on the
standardisation of data practices. Traditional funding agencies
are perhaps less likely to place emphasis on infrastructure,
and so scientists are less incentivised to standardise their
data practices.
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